Genolab secures $1.47 million in Series A round of financing - MarketLine Financial Deals

Genolab secures $1.47 million in Series A round of financing

Genolab secures $1.47 million in Series A round of financing - MarketLine Financial Deals
Genolab secures $1.47 million in Series A round of financing
Published May 20, 2010
1 pages — Published May 20, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Genolab, a Brazilian medical diagnostics company, has secured EUR1.2 million in Series A round of financing led by Berchmann Capital SRL.

  
Source:
Document ID
MA25497_100525
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Genolab secures $1.47 million in Series A round of financing" May 20, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Genolab-secures-1-47-million-in-Series-A-round-of-financing-2052-33441>
  
APA:
MarketLine Financial Deals. (2010). Genolab secures $1.47 million in Series A round of financing May 20, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Genolab-secures-1-47-million-in-Series-A-round-of-financing-2052-33441>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.